Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study-Reference-Cited by-同舟云学术

Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study

Published:2016-07-12 Issue:1 Volume:18 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Langballe Rikke, ,Mellemkjær Lene,Malone Kathleen E.,Lynch Charles F.,John Esther M.,Knight Julia A.,Bernstein Leslie,Brooks Jennifer,Andersson Michael,Reiner Anne S.,Liang Xiaolin,Woods Meghan,Concannon Patrick J.,Bernstein Jonine L.

Funder

National Institutes of Health

The Scientific Committee of the Danish Cancer Society

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-016-0726-0.pdf

Reference24 articles.

1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–717.

2. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, Clarke M, Cutter D, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378(9793):771–84. doi: 10.1016/S0140-6736(11)60993-8 .

3. Cook LS, Weiss NS, Schwartz SM, White E, McKnight B, Moore DE, et al. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. J Natl Cancer Inst. 1995;87(18):1359–64.

4. Schaapveld M, Visser O, Louwman WJ, Willemse PH, de Vries EG, van der Graaf WT, et al. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat. 2008;110(1):189–97.

5. Hooning MJ, Aleman BM, Hauptmann M, Baaijens MH, Klijn JG, Noyon R, et al. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. J Clin Oncol. 2008;26(34):5561–8.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agreement of medical record abstraction and self‐report of breast cancer treatment with an extended recall window;Cancer;2024-06-28

2. Case-Case Genome-Wide Analyses Identify Subtype-Informative Variants That Confer Risk for Breast Cancer;Cancer Research;2024-06-04

3. Construction and Validation of a Nomogram Predicting the Overall Survival Benefit of Unilateral Breast Cancer Patients Undergoing Contralateral Prophylactic Mastectomy;Clinical Breast Cancer;2024-06

4. A genome-wide association study of contralateral breast cancer in the Women’s Environmental Cancer and Radiation Epidemiology Study;Breast Cancer Research;2024-01-23

5. Trends in Radiation Dose to the Contralateral Breast During Breast Cancer Radiation Therapy;Radiation Research;2023-08-16